UK Markets closed
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • FTSE 250

    18,636.98
    -29.80 (-0.16%)
     
  • AIM

    875.21
    -1.01 (-0.12%)
     
  • GBP/EUR

    1.1593
    -0.0018 (-0.16%)
     
  • GBP/USD

    1.2103
    -0.0072 (-0.5930%)
     
  • BTC-GBP

    15,805.75
    -152.72 (-0.96%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • DOW

    31,097.26
    +321.83 (+1.05%)
     
  • CRUDE OIL

    108.46
    +2.70 (+2.55%)
     
  • GOLD FUTURES

    1,812.90
    +5.60 (+0.31%)
     
  • NIKKEI 225

    25,935.62
    -457.42 (-1.73%)
     
  • HANG SENG

    21,859.79
    -137.10 (-0.62%)
     
  • DAX

    12,813.03
    +29.26 (+0.23%)
     
  • CAC 40

    5,931.06
    +8.20 (+0.14%)
     

Plasma Protein Therapeutics Market Report 2022-2032

·4-min read
ReportLinker
ReportLinker

Forecasts by Product (Immunoglobulins, Albumin, Coagulation Factors, C1-Esterase Inhibitor (C1-INH), Other), by Application (Hemophilia, Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura (ITP), Secondary Immunodeficiency, Hereditary Angioedema, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios

New York, June 14, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Plasma Protein Therapeutics Market Report 2022-2032" - https://www.reportlinker.com/p06285614/?utm_source=GNW

Plasma Protein Therapeutics Market, 2022 to 2032- our new study reveals the latest industry trends, R&D progress, and predicted revenues

Increase of Blood Donations to Fuel Demand Across Low and Middle Income Countries

Due to the worldwide initiatives, a rise in voluntary, unpaid blood donations from low- and middle-income countries has been noted to fulfil the unmet need for red blood cell concentrates. In high-income nations, however, demand for red blood cells has been steadily declining, and with global economic advancements, this trend is anticipated to continue. As a result, it seems that the quantity of recovered plasma accessible for plasma fractionation is diminishing.

COVID-19 Disruption Hampering the Industry’s Ability to Keep Pace with Growing Patient Pool

Plasma products are made possible by a meticulously designed, complicated system of willing donors, donation facilities, worldwide manufacturing networks, and pharmaceutical product distribution routes, which is generally reliable under normal conditions. The situation has become complicated with the outbreak of the coronavirus disease pandemic. The pandemic had a substantial influence on the well-developed and balanced system of plasma procurement beginning in early 2020, greatly impeding the industry’s capacity to keep up with expanding patient demand for these life-changing medications.

Discover how to stay ahead

Our 220+ page report provides 180+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at the overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Plasma Protein Therapeutics Market. See how to exploit the opportunities.

Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles, and commercial developments.

Discover sales predictions for the world market and sub-markets

Product
• Immunoglobulins
• Albumin
• Coagulation Factors
• C1-Esterase Inhibitor (C1-INH)
• Other Products

Applications
• Hemophilia
• Primary Immunodeficiency Disorder (PID)
• Idiopathic Thrombocytopenic Purpura (ITP)
• Secondary Immunodeficiency
• Hereditary Angioedema
• Others

Region
• North America
• Europe
• Asia Pacific
• Latin America
• MEA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

By Region

North America
• U.S.
• Canada

Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa

Leading companies and the potential for market growth

Overall world revenue for Plasma Protein Therapeutics Market will surpass US$28 billion in 2022, our work calculates. We predict strong revenue growth through 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Plasma Protein Therapeutics Market report helps you

In summary, our 220+ page report provides you with the following knowledge: 
• Revenue forecasts to 2032 for Plasma Protein Therapeutics Market, with forecasts for 5 segmentations of the plasma protein therapeutics market, with forecasts for product and applications sub-segments each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues 
• Revenue forecasts to 2032 for five regional and 20 key national markets– See forecasts for the Plasma Protein Therapeutics Market in North America, Europe, Asia Pacific, and Rest of the World. These regional markets have been further bifurcated by countries including the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies. 
• Prospects for established firms and those seeking to enter the market– including company profiles for 9 of the companies involved in the Plasma Protein Therapeutics Market. Some of the companies profiled in this report include ADMA Biologics Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols SA, Kedrion SpA, Octapharma USA Inc., and Takeda Pharmaceutical Company Ltd, among other prominent players. 



Read the full report: https://www.reportlinker.com/p06285614/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting